1Research Associate, National Ganga River Basin Authority, Central Pollution Control Board, PariveshBhawan, East Arjun Nagar, Delhi-110 032
2Ph.D. Student, Department of Microbiology, Chaudhary Charan Singh Haryana Agricultural University, Hisar-125 004, Haryana
3Professor, Department of Microbiology, Chaudhary Charan Singh Haryana Agricultural University, Hisar-125 004, Haryana
*Corresponding Author: E-mail: anugoel.micro@gmail.com
Online published on 13 May, 2015.
Ebola virus disease (EVD) is a rare severe disease, often fatal, caused by the Ebola virus. It is transmitted through direct contact with blood or other bodily fluids (e.g. saliva, urine) from infected people, dead or alive. This includes unprotected sexual contact with patients up to seven weeks after they have recovered. Ebola virus does not transmit through the air as influenza does. After two days and up to 21 days following exposure to the virus, disease may start suddenly with fever, muscle aches, weakness, headache and sore throat. The next stage of disease is characterised by vomiting, diarrhoea, rash and failure of the liver and kidneys. Some patients also have heavy internal and external bleeding and multiorgan failure. There is no specific vaccine or treatment for the disease, but World Health Organization and other regulatory partners are currently working to identify potential viable treatments.
Virus, Ebola, Diagnosis, Therapy
